startup

SciRhom

Developing drugs to combat life-threatening diseases.
  • Life Science & Healthcare
  • Startup Stage
  • Other
  • B2B2C
  • 2016
  • 1-10 Employees
  • Found
  • Planegg, DE
  • Login required
  • SciRhom GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile
Jens Ruhe Geschäftsführer
Jan Poth Geschäftsführer

Alumni

2020 - 2022 Andreas Jenne
Geschäftsführer

News about SciRhom

Latest feature of SciRhom:

63 Mio. Euro Series-A-Runde von SciRhom
63 Mio. Euro Series-A-Runde von SciRhom
Das Münchener Biopharma-Unternehmen entwickelt innovative Antikörper gegen Autoimmunerkrankungen. Die 63 Millionen Euro fließen in die Entwicklung neuer Autoimmuntherapien.
Startbase
09.07.2024 »

Recent mentions of SciRhom in podcasts & videos:

Jobs at SciRhom:

Related companies

High-Tech Gründerfonds
Investor 2005 Bonn High-Tech Gründerfonds HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Bayern Kapital
Investor Landshut Bayern Kapital Subsidiary of LfA Förderbank Bayern invests venture capital in companies located in Bavaria.
Startup 2019 Planegg Tubulis Reimagining Antibody Drug Conjugates Protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Mermaid Bio
Startup 2022 München Mermaid Bio
Startup 2008 Mainz BioNTech Development of novel therapies against cancer & infectious diseases.

Other Startups nearby

Startup 2010 Planegg Lindis Biotech Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup 2013 Planegg Bind-X Industrial applications in the field of biotechnology.
Startup 2016 Planegg PreOmics Develops and provides technologies for mass spectrometry-based proteomics.
Startup 2015 Planegg Atriva Therapeutics Antiviral therapies against several severe respiratory viral infections with high unmet medical need, such as influenza and COVID-19.
Startup 2018 Planegg adivo Development of specific antibodies for veterinary medicine.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen